Julie Gerberding

Julie Louise Gerberding MD, MPH, is the newly-appointed Director for the Centers for Disease Control and Prevention (CDC). She is an Associate Clinical Professor of Medicine (Infectious Diseases) at Emory University and is on leave of absence as an Associate Professor of Medicine (Infectious Diseases) and Epidemiology and Biostatistics at the University of California, San Francisco (USCF). She earned her B.A. degree magna cum laude in chemistry and biology and M.D. degree at Case Western Reserve University in Cleveland, Ohio and then completed her internship and residency in internal medicine at UCSF, where she also served as Chief Medical Resident before completing her fellowship in Clinical Pharmacology and Infectious Diseases at UCSF. She earned her MPH degree at the University of California, Berkeley in 1990.

As Acting Deputy Director of National Center for Infectious Diseases, Dr. Gerberding played a major role in leading CDC's response to the anthrax bioterrorism events last fall. She joined CDC in 1998 as Director, Division of Healthcare Quality Promotion, where she developed CDC's patient safety initiatives and other programs to prevent infections, antimicrobial resistance, and medical errors in healthcare settings. At UCSF, she was Director of the Prevention Epicenter, a multidisciplinary service, teaching, and research program that focused on preventing infections in patients and their healthcare providers.

Dr. Gerberding is a member of Phi Beta Kappa, Alpha Omega Alpha (medical honor society), American Society for Clinical Investigation (ASCI), American College of Physicians, and is a Fellow in the Infectious Diseases Society of America (IDSA). She has served as Chair and Co-chair of the IDSA's Committee on Professional Development and Diversity, was elected to serve as a member of the Nominations Committee, and is currently Co-chair of the Annual Program Committee.

Dr. Gerberding is also a member of the Society for Healthcare Epidemiology of America and has served as a member of the AIDS/Tuberculosis Committee, is currently serving her third year as Academic Counselor on the SHEA Board, and will be President of SHEA in 2003. In the past, she served as a member of NCID/CDC Board of Scientific Counselors, the CDC HIV Advisory Committee, and the Scientific Program Committee, National Conference on Human Retroviruses. She has also been a consultant to NIH, AMA, CDC, OSHA, National AIDS Commission, US Congress OTA, and WHO.

Her editorial activities have included appointments to the Editorial Board, Annals of Internal Medicine; Associate Editor, American Journal of Medicine, and service as a peer-reviewer for numerous internal medicine, infectious diseases, and epidemiology journals. Her scientific interests encompass infection prevention / healthcare quality promotion among patients and their healthcare providers.

She has authored/co-authored more than 120 peer-reviewed publications and textbook chapters and contributed to numerous guidelines and policies relevant to HIV prevention, post-exposure prophylaxis, management of infected healthcare personnel, and healthcare-associated infection prevention and control.

Back To Top